The ARTERY FIRST Approach for Resection of Pancreatic Head Cancer

NCT ID: NCT01332773

Last Updated: 2011-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

124 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-31

Study Completion Date

2011-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To show whether the artery first approach leads to equal or less rate of positive resection margins in pancreatic head cancer than the standard technique (ppWhipple only with standard Kocher's manoeuvre)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective non-randomized trial with two study groups. The trial is designed to show if the ARTERY FIRST approach reduces the rate of R1 resections in patients undergoing surgery for cancer of the pancreatic head.

After the diagnosis of cancer of the pancreatic head by clinical, laboratory and imaging evaluation patients who are scheduled for resection will be screened for inclusion into the trial. Informed consent is obtained at least on the day before surgery and patients meeting the eligibility criteria will be enrolled into the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatic Head Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Artery first group

The basic principle of the "artery first" approach is the early identification of the SMA at its origin at the aorta with the further resection then being guided by its anatomic course.

The dissection is carried cephalad along the aorta until the origin of the SMA is reached. The posterior and right aspect of the SMA is then dissected over a few centimeters. On the right side of the SMA a replaced or accessory right hepatic artery, if present, will be identified and preserved. This maneuver should be done, if infiltration of the SMA is suspected as the procedure can be terminated at this point. Once the situation at the SMA is assessed and resectability is confirmed resection will be done.

Group Type EXPERIMENTAL

Artery first procedure

Intervention Type PROCEDURE

early identification of SMA to evaluate infiltration

Conventional Group

A wide Kocher manoeuver is performed to fully mobilize the duodenum and the head of the pancreas. The colonic mesentery on the right side is separated from the anterior surface of the duodenum and the head of the pancreas. The size of the tumor and its relation to the superior mesenteric artery, the celiac trunk, the mesentery, the portal vein, and the superior mesenteric vein is assessed. If resectability is given a Kausch-Whipple's resection is performed.

Group Type ACTIVE_COMPARATOR

No artery first procedure

Intervention Type PROCEDURE

conventional exposure and preparation (Kocher's manoeuvre) before transection of pancreatic parenchyma

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Artery first procedure

early identification of SMA to evaluate infiltration

Intervention Type PROCEDURE

No artery first procedure

conventional exposure and preparation (Kocher's manoeuvre) before transection of pancreatic parenchyma

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pancreatic head cancer (diagnosis by clinical, laboratory and radiological evaluation)
* Patients scheduled for curative resection
* No evidence of distant metastases
* Age equal or greater than 18 years
* Informed consent

Exclusion Criteria

* Expected lack of compliance
* Impaired mental state or language problems
* patient having had neoadjuvant radiochemotherapy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Heidelberg University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of General, Visceral and Transplantation Surgery, University of Heidelberg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of General, Visceral and Transplantation Surgery, University of Heidelberg

Heidelberg, Baden-Wurttemberg, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nuh N. Rahbari, MD

Role: CONTACT

+496221 ext. 39448

Heike Elbers

Role: CONTACT

+496221 ext. 36976

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rahbari

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NNR-7

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.